Ofatumumab - a new high-efficacy treatment for relapsing forms of multiple sclerosis

被引：0

作者：

Valis, M. ^{[1
]}

Haluskova, S. ^{[1
]}

机构：

[1] Neurol Klinika LF UK FN Hradec Kralove, Sokolska 581, Hradec Kralove 50005, Czech Republic

来源：

CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE | 2021年 / 84卷 / 05期

关键词：

multiple sclerosis; treatment; antibodies monoclonal; ofatumumab; DISEASE-ACTIVITY; NO EVIDENCE; B-CELLS; OCRELIZUMAB; THERAPIES; ANTIBODY;

D O I：

10.48095/cccsnn2021436

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

There has been tremendous progress in the treatment of MS over recent years. The concept of early treatment to achieve better outcomes in MS has clearly emerged, fully supported by long-term data. The effi cacy of anti-CD20 monoclonal antibodies in the treatment of MS has been confi rmed in clinical trials. Ofatumumab is a fully-humanized anti-CD20 monoclonal antibody approved for the treatment of adult patients with relapsing-remitting MS. Ofatumumab showed high effi cacy and a favorable safety profile in phase III clinical trials, offering the first B-cell therapy that can be subcutaneously self-administered at home.

引用

页码：436 / 440

页数：5

共 50 条

[41] Cladribine to Treat Relapsing Forms of Multiple Sclerosis [J].

Gavin Giovannoni .

Neurotherapeutics, 2017, 14 :874-887

[42] Cladribine to Treat Relapsing Forms of Multiple Sclerosis [J].

Giovannoni, Gavin .

NEUROTHERAPEUTICS, 2017, 14 (04) :874-887

[43] Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis [J].

Turner, Benjamin ;

Cree, Bruce A. C. ;

Kappos, Ludwig ;

Montalban, Xavier ;

Papeix, Caroline ;

Wolinsky, Jerry S. ;

Buffels, Regine ;

Fiore, Damian ;

Garren, Hideki ;

Han, Jian ;

Hauser, Stephen L. .

JOURNAL OF NEUROLOGY, 2019, 266 (05) :1182-1193

[44] Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis [J].

Benjamin Turner ;

Bruce A. C. Cree ;

Ludwig Kappos ;

Xavier Montalban ;

Caroline Papeix ;

Jerry S. Wolinsky ;

Regine Buffels ;

Damian Fiore ;

Hideki Garren ;

Jian Han ;

Stephen L. Hauser .

Journal of Neurology, 2019, 266 :1182-1193

[45] Ofatumumab and Early Immunological Cells Subset Characterization in Naive Relapsing Multiple Sclerosis Patients: A Real-World Study [J].

D'Amico, Emanuele ;

Zanghi, Aurora ;

Fantozzi, Roberta ;

Centonze, Diego ;

Avolio, Carlo .

CURRENT NEUROPHARMACOLOGY, 2023, 21 (12) :2563-2566

[46] The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment [J].

Hauser, Stephen L. ;

Kappos, Ludwig ;

Bar-Or, Amit ;

Wiendl, Heinz ;

Paling, David ;

Williams, Mitzi ;

Gold, Ralf ;

Chan, Andrew ;

Milo, Ron ;

Das Gupta, Ayan ;

Karlsson, Goeril ;

Sullivan, Roseanne ;

Graham, Gordon ;

Merschhemke, Martin ;

Haring, Dieter A. ;

Vermersch, Patrick .

NEUROLOGY AND THERAPY, 2023, 12 (05) :1491-1515

[47] Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management [J].

Oreja-Guevara, Celia ;

Martinez-Yelamos, Sergio ;

Eichau, Sara ;

Llaneza, Miguel Angel ;

Martin-Martinez, Jesus ;

Pena-Martinez, Joaquin ;

Meca-Lallana, Virginia ;

Alonso-Torres, Ana Maria ;

Moral-Torres, Ester ;

Rio, Jordi ;

Calles, Carmen ;

Ares-Luque, Adrian ;

Ramio-Torrenta, Lluis ;

Marzo-Sola, Maria Eugenia ;

Prieto, Jose Maria ;

Martinez-Gines, Maria Luisa ;

Arroyo, Rafael ;

Otano-Martinez, Maria Angeles ;

Brieva-Ruiz, Luis ;

Gomez-Gutierrez, Montserrat ;

Rodriguez-Antiguedad, Alfredo ;

Sanchez-Seco, Victoria Galan ;

Costa-Frossard, Lucienne ;

Hernandez-Perez, Miguel Angel ;

Landete-Pascual, Lamberto ;

Gonzalez-Platas, Montserrat ;

Meca-Lallana, Jose E. .

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2024, 17

[48] Real-World Comparison of High-Efficacy Versus Non-High-Efficacy Therapies in Multiple Sclerosis [J].

Al-Araji, Sarmad ;

Moccia, Marcello ;

Bianchi, Alessia ;

Yam, Charmaine ;

Hamed, Weaam ;

Mohamud, Suraya ;

Thompson, Alan J. ;

Barkhof, Frederik ;

Toosy, Ahmed T. ;

Ciccarelli, Olga .

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2025,

[49] Subcutaneously delivered natalizumab for the treatment of highly active relapsing-remitting multiple sclerosis [J].

Haluskova, S. ;

Valis, M. .

CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2022, 85 (03) :206-212

[50] Comparison of efficacy and safety of oral agents for the treatment of relapsing-remitting multiple sclerosis [J].

Guarnera, Cristina ;

Bramanti, Placido ;

Mazzon, Emanuela .

DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 :2193-2207

← 1 2 3 4 5 →